Talk:Novartis challenges patent rejection in India

Médecins Sans Frontières reports

• A victory for Novartis could mean death for millions (The Hindu - in English)
• Novartis against India: The court will decide (New Internationalist - in English)
• Supreme Court of India hears Novartis about impeachment of India's patent law (IP Watch - in English)
• Novartis goes to court in India for patent rejection (Médecins Sans Frontières - in German)

Review of revision 1444733 [Not ready]

Revision 1444733 of this article has been reviewed by Blood Red Sandman (talk · contribs) and found not ready at 12:15, 23 March 2012 (UTC). Copyright: Not reviewed. Please address other issues. Newsworthiness: Passed Verifiability: Not reviewed. Please address other issues. NPOV: Not ready: This is quite biased against Novatis. The headline is emotive, there is an early meantion of "monopoly", there is no real comment from Novartis. Style: Not reviewed. Please address other issues. Comments by reviewer: The sentiment in the article is quite understandable, but that makes it no more suitable. Questions about the above? Ask. If possible, please address the above issues then resubmit the article for another review (by replacing {{tasks}} in the article with {{review}}). This talk page will be updated with subsequent reviews.

Revision 1444733 of this article has been reviewed by Blood Red Sandman (talk · contribs) and found not ready at 12:15, 23 March 2012 (UTC). Copyright: Not reviewed. Please address other issues. Newsworthiness: Passed Verifiability: Not reviewed. Please address other issues. NPOV: Not ready: This is quite biased against Novatis. The headline is emotive, there is an early meantion of "monopoly", there is no real comment from Novartis. Style: Not reviewed. Please address other issues. Comments by reviewer: The sentiment in the article is quite understandable, but that makes it no more suitable. Questions about the above? Ask. If possible, please address the above issues then resubmit the article for another review (by replacing {{tasks}} in the article with {{review}}). This talk page will be updated with subsequent reviews.

The headline has been de-emotionalized. --Bernhard Fastenrath 18:01, 23 March 2012 (UTC)

A statement about the position of Novartis has been added. --Bernhard Fastenrath 18:11, 23 March 2012 (UTC)

Mentioning a monopoly is not a problem, because owning an exclusive license for a medicament is a kind of monopoly, isn't it? --Bernhard Fastenrath 18:13, 23 March 2012 (UTC)

In English usage, at least, monopoly is not the usual term for this and its use for such comes across as aggressively negative. The objective is to describe just the facts and leave analysis to the reader.

The first paragraph has a lot of detail in it, I see. It should be a succinct summary of as many as reasonably possible of the basic questions about the news event; details belong in later paragraphs. --Pi zero (talk) 18:33, 23 March 2012 (UTC)

I removed the word 'monopoly'. It was used by Médecins Sans Frontières, who have assumed a partisan view in this case and I was not and am not aware of an 'aggressively negative' connotation in this context, maybe subtly negative? I split the first paragraph and moved one more of the five W's into the first paragraph. --Bernhard Fastenrath 20:15, 23 March 2012 (UTC)

Review of revision 1448036 [Passed]

Revision 1448036 of this article has been reviewed by Cirt (talk · contribs) and has passed its review at 18:39, 26 March 2012 (UTC). Copyright: Passed Newsworthiness: Passed Verifiability: Passed NPOV: Passed Style: Passed Comments by reviewer: Looks a bit more NPOV this time round. The reviewed revision should automatically have been edited by removing {{Review}} and adding {{Publish}} at the bottom, and the edit sighted; if this did not happen, it may be done manually by a reviewer.

Revision 1448036 of this article has been reviewed by Cirt (talk · contribs) and has passed its review at 18:39, 26 March 2012 (UTC). Copyright: Passed Newsworthiness: Passed Verifiability: Passed NPOV: Passed Style: Passed Comments by reviewer: Looks a bit more NPOV this time round. The reviewed revision should automatically have been edited by removing {{Review}} and adding {{Publish}} at the bottom, and the edit sighted; if this did not happen, it may be done manually by a reviewer.

Misleading

Sorry, I'm new to Wikinews, so not sure if I'm using the right format. In any case, I believe the following is a bit misleading: "Should the complaint be successful millions of people may no longer be able to purchase necessary medication." If the complaint is successful, the pharmaceutical company would retain a monopoly on the meds, meaning that the poor people would still not be able to afford them. So, the statement is technically true. However, it's not that the ruling would somehow prohibit them from purchasing the meds. I think this should be clarified in the article.JoelWhy (talk) 20:00, 27 March 2012 (UTC)

It's unfortunate it's not better worded, I agree. Note though that substantive changes to an article are only allowed for the first 24 hours after review, which have already passed. --Pi zero (talk) 20:29, 27 March 2012 (UTC)